These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24405726)

  • 1. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
    Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy?
    Engels MA; Heijboer AC; Blankenstein MA; van Vugt JM
    Prenat Diagn; 2011 Dec; 31(13):1241-5. PubMed ID: 22025131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital.
    Lo TK; Lai FK; Leung WC; Lau WL; Tang LC; Chin RK
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):914-9. PubMed ID: 19883260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age independent first trimester screening for Down syndrome: improvement in test performance.
    Engels MA; Twisk JW; Blankenstein MA; van Vugt JM
    Prenat Diagn; 2013 Sep; 33(9):884-8. PubMed ID: 23682007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
    van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L;
    Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age.
    Peuhkurinen S; Laitinen P; Ryynanen M; Marttala J
    J Eval Clin Pract; 2013 Apr; 19(2):324-6. PubMed ID: 22458815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors determining uptake of invasive testing following first-trimester combined testing.
    Lichtenbelt KD; Schuring-Blom GH; van der Burg N; Page-Christiaens GC; Knoers NV; Schielen PC; Koster MP
    Prenat Diagn; 2013 Apr; 33(4):328-33. PubMed ID: 23417693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.